Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Helping EGFR inhibition to block cancer

Nature Neuroscience volume 20, pages 1035–1037 (2017)Cite this article

Subjects

Effectiveness of EGFR treatment is impaired through an early adaptive response. TNF–JNK–Axl–ERK signaling contributes to this primary resistance to EGFR inhibition and might serve as novel target to improve EGFR inhibition.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: GBM cells escape EGFR inhibition by activation of the TNF–JNK–Axl–ERK signaling axis.

Kim Caesar/Springer Nature

References

  1. Brennan, C.W. et al. Cell 155, 462–477 (2013).

    Article  CAS  Google Scholar 

  2. Sugawa, N., Ekstrand, A.J., James, C.D. & Collins, V.P. Proc. Natl. Acad. Sci. USA 87, 8602–8606 (1990).

    Article  CAS  Google Scholar 

  3. Reardon, D. A., Wen, P. Y. & Mellinghoff, I. K. Neuro Oncol. 16 (Suppl. 8), 7–13 (2014).

    Article  Google Scholar 

  4. Guo, G. et al. Nat. Neurosci. 20, 1074–1084 (2017).

    Article  CAS  Google Scholar 

  5. Jahani-Asl, A. et al. Nat. Neurosci. 19, 798–806 (2016).

    Article  CAS  Google Scholar 

  6. Montgomery, R.B., Moscatello, D.K., Wong, A.J., Cooper, J.A. & Stahl, W.L. J. Biol. Chem. 270, 30562–30566 (1995).

    Article  CAS  Google Scholar 

  7. Huang, P.H. et al. Proc. Natl. Acad. Sci. USA 104, 12867–12872 (2007).

    Article  CAS  Google Scholar 

  8. Eskilsson, E. et al. Neuro Oncol. 18, 1644–1655 (2016).

    Article  CAS  Google Scholar 

  9. Weller, M. et al. Neuro-oncol. 18 (Suppl. 6), 17–18 (2016).

    Article  Google Scholar 

  10. Westphal, M. et al. Eur. J. Cancer 51, 522–532 (2015).

    Article  CAS  Google Scholar 

  11. Sampson, J.H. et al. J. Clin. Oncol. 28, 4722–4729 (2010).

    Article  Google Scholar 

  12. Akhavan, D. et al. Cancer Discov. 3, 534–547 (2013).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Experimental Neurosurgery, Department of Neurosurgery, University Hospital Heidelberg, Heidelberg, Germany

    Rolf Warta & Christel Herold-Mende

Authors
  1. Rolf Warta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christel Herold-Mende
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christel Herold-Mende.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Warta, R., Herold-Mende, C. Helping EGFR inhibition to block cancer. Nat Neurosci 20, 1035–1037 (2017). https://doi.org/10.1038/nn.4605

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nn.4605

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer